INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "TREATMENT AND PREVENTION OF AGE-RELATED MACULAR DEGENERATION USING A CETP INHIBITOR"

GENEVA, May 11 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2-351411 DC Naarden) filed a patent application (PCT/EP2023/080690) for "TREATMENT AND PREVENTION OF AGE-RELATED MACULAR DEGENERATION USING A CETP INHIBITOR" on Nov 03, 2023. With publication no. WO/2025/093129, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KASTELEIN, Johannes Jacob Pieter (Gooimeer 2-351411 DC Naarden), DITMARSCH, Marc (Gooimeer 2-351411 DC Naarden), NIESOR, Eric (13c Chemin de BonmontL260 Nyon)

Abstract: This invention relates to methods and comp...